PharmiWeb38m
BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
ContractBRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma20-Sep-2024 / 19:47 CET/CESTDisclosure of ...
PharmiWeb5h
ZetrOZ Systems Provides Targeted Treatment for Common Sports Injuries
The sam® wearable ultrasound biotechnology is purpose-built to treat the most common athletic injuries, accelerating soft tissue healing and reducing the need for surgery or pain medication.TRUMBULL, ...
PharmiWeb5h
DISCOVER FH Collaboration With Family Heart Foundation, UT Southwestern, and Partners
LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular diseaseOXFORD, ENGLAND / ACCESSWIRE / September 20, 2024 / GENinCode Plc (AIM:GENI), the genetics ...
PharmiWeb6h
Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts
SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care ...
PharmiWeb9h
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to ...
PharmiWeb18h
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in the world, as an aversive agent for its Aversa™ Fentanyl abuse deterrent fentanyl ...
PharmiWeb22h
Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO
Holds 9 Granted Patents and 26 Pending Applications for the Catamaran® SI Joint Fusion System Worldwide LOS GATOS, CA / ACCESSWIRE / September 19, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or ...
PharmiWeb1d
San Francisco Medical Waste Disposal Firm Mitigates Increase in Needlestick Injuries With Key Resource
Each year, the CDC estimates that around 385,000 healthcare workers in the United States suffer from needlestick and ...
PharmiWeb1d
Renovos Biologics strengthens its Board’s US expertise with appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director
Lisa Ferrara, Ph.D., brings over 30 years of experience in orthopaedic medical device innovation and regulatory strategy in the USA·       Dr Ferrara will play a pivotal role in advancing Renovos’ ...
PharmiWeb1d
Bayer submits application to MHRA for elinzanetant…
Bayer has submitted a Marketing Authorisation Application (MAA) to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for the investigational compound elinzanetant for the treatment ...
PharmiWeb1d
Aston Institute for Membrane Excellence celebrates official launch with multidisciplinary event
Aston Institute for Membrane Excellence held its official academic launch event on 13 SeptemberMore than 100 biologists, chemists, physicists and engineers gathered at Aston University to learn about ...
PharmiWeb1d
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced the appointment of Matthias Will, M.D., as Chief ...